海绵 (L3) 中相酶的脂质兴奋剂
Christopher Brasnett1, Adam M Squires2, Andrew J Smith3
1School of Physics, University of Bristol, Tyndall Avenue, Bristol, BS8 1FD, UK. annela.seddon@bristol.ac.uk.
Soft matter
|August 21, 2023
概括
这项研究显示,添加特定的脂质,如胆固醇和DOPG,可以显著影响海绵 (L3) 脂质介质酶的形成和稳定性. 这一发现对于药物输送和膜蛋白研究的应用至关重要.
科学领域:
- 脂质自我组装和软物质物理学.
背景情况:
- 脂质中位相多态性对于药物输送和膜蛋白质结晶学等应用至关重要.
- 海绵 (L3) 中相,一个缺乏长距离对称性的双连续结构,很重要,但研究不足.
- 在单烯/水系统中,L3相形成受到诸如布坦醇之类的添加剂的影响,这些添加剂会改变膜性质.
研究的目的:
- 为了研究多邦脂质对L3 mesophase的形成和稳定性的影响.
- 了解不同的脂质结构和电荷如何影响L3相组成和特征.
- 为了确定形成更大,更稳定的L3中相的条件.
主要方法:
- 系统地将各种多脂 (DOPE,胆固醇,DOPC,DDM,DOPG) 添加到单油/水系统中.
- 由此产生的脂质中位相的表征及其组成极限.
- 分析L3阶段的结构特性,包括特征长度.
主要成果:
- 类似于单烯 (DOPE,胆固醇) 的静电中性脂质对L3相形成的影响最小.
- 其他脂质 (DOPC,DDM) 显著降低了L3阶段形成的组成范围.
- 将胆固醇与离子脂质DOPG结合在一起,导致观察到的最大稳定的L3中相,超过220 Å.
结论:
- L3中位相的形成和稳定性对多邦脂质的类型和电荷高度敏感.
- 特定的脂质组合,特别是胆固醇与像DOPG这样的离子脂质,可以稳定和扩大L3阶段.
- 这些发现为控制软物质系统中的脂质自我组合以及针对性应用提供了关键的见解.
相关概念视频
Nitric Oxide Signaling Pathway
Nitric oxide (NO), an inorganic gas, acts as a potent second messenger in most animal and plant tissues. NO diffuses out of the cells that produce it and enters the neighboring cells to generate a downstream response. NO synthase (NOS) catalyzes NO production by the deamination of the amino acid arginine. There are three isoforms of NOS. Endothelial cells have endothelial NOS (eNOS), nerve and muscle cells have neuronal NOS (nNOS), and macrophages produce inducible NOS (iNOS) upon exposure to...
Indirect-Acting Cholinergic Agonists: Mechanism of Action
Indirect-acting cholinergic agonists work by interacting with an enzyme called acetylcholinesterase (AChE) in the synaptic cleft. They can be reversible or irreversible inhibitors and have different effects on the enzyme.
Reversible inhibitors like edrophonium bind to a specific part of the enzyme called the anionic catalytic site. They form noncovalent bonds, which means they are not strongly attached to the enzyme. This creates a temporary and less stable enzyme–inhibitor complex, leading to...
Reversible inhibitors like edrophonium bind to a specific part of the enzyme called the anionic catalytic site. They form noncovalent bonds, which means they are not strongly attached to the enzyme. This creates a temporary and less stable enzyme–inhibitor complex, leading to...
Peripherally and Centrally Acting Muscle Relaxants: A Comparison
Skeletal muscle relaxants can target the central nervous system [CNS] to reduce muscle tension or act directly at the neuromuscular junction to induce temporary paralysis. These two classes of muscle relaxants are called centrally acting muscle relaxants and peripherally acting muscle relaxants. They differ in their action, mechanism, administration route, and clinical uses.
Centrally acting muscle relaxants can be further divided into spasmolytic and antispasmodic drugs. Spasmolytic drugs,...
Centrally acting muscle relaxants can be further divided into spasmolytic and antispasmodic drugs. Spasmolytic drugs,...
Centrally Acting Muscle Relaxants: Therapeutic Uses
Centrally acting muscle relaxants reduce muscle tone and tension by interfering with the postsynaptic reflexes in the central nervous system.
Centrally acting drugs are classified into spasmolytic and antispasmodic drugs. Spasmolytic drugs such as baclofen, diazepam, and tizanidine inhibit spinal motor neurons and decrease muscle tone. Spasmolytic drugs are administered for severe and chronic spasms due to multiple sclerosis, cerebral palsy, stroke, and spinal cord and muscle injuries. However,...
Centrally acting drugs are classified into spasmolytic and antispasmodic drugs. Spasmolytic drugs such as baclofen, diazepam, and tizanidine inhibit spinal motor neurons and decrease muscle tone. Spasmolytic drugs are administered for severe and chronic spasms due to multiple sclerosis, cerebral palsy, stroke, and spinal cord and muscle injuries. However,...


